Know Cancer

or
forgot password
  • cancer clinical trials in fort scott, KS

  • Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Lung Cancer
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Esophageal Cancer, Gastric Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Breast Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Recurrent Mantle Cell Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Lung Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Endometrial Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Brain and Central Nervous System Tumors
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Colorectal Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Malignant Mesothelioma
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Lymphoma
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Lung Cancer
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Leukemia
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Brain and Central Nervous System Tumors
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Cancer Center of Kansas - Fort Scott
    Fort Scott, Kansas 66701
    Brain and Central Nervous System Tumors